Adding free to total prostate-specific antigen levels in trials of prostate cancer screening

Wald NJ; Watt HC; George L; Knekt P; Helzisouer KJ; Tuomilehto J

Adding free to total prostate-specific antigen levels in trials of prostate cancer screening

Wald NJ; Watt HC; George L; Knekt P; Helzisouer KJ; Tuomilehto J (2000)

Tätä artikkelia/julkaisua ei ole tallennettu Julkariin. Julkaisun tiedoissa voi kuitenkin olla linkki toisaalle tallennettuun artikkeliin/julkaisuun.

Wald NJ

Watt HC

George L

Knekt P

Helzisouer KJ

Tuomilehto J

2000

Näytä kaikki kuvailutiedot

Br J Cancer : 3

Kokoelmat

Artikkelit [13786]

Adding free to total prostate-specific antigen levels in trials of prostate cancer screening

Wald NJ; Watt HC; George L; Knekt P; Helzisouer KJ; Tuomilehto J (2000)

Kokoelmat

Samankaltainen aineisto

Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) ﻿

PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3) ﻿

A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium ﻿

Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)

PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)

A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium